Cargando…
Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target
Facioscapulohumeral muscular dystrophy (FSHD) is characterised by descending skeletal muscle weakness and wasting. FSHD is caused by mis-expression of the transcription factor DUX4, which is linked to oxidative stress, a condition especially detrimental to skeletal muscle with its high metabolic act...
Autores principales: | Heher, Philipp, Ganassi, Massimo, Weidinger, Adelheid, Engquist, Elise N., Pruller, Johanna, Nguyen, Thuy Hang, Tassin, Alexandra, Declèves, Anne-Emilie, Mamchaoui, Kamel, Banerji, Christopher R.S., Grillari, Johannes, Kozlov, Andrey V., Zammit, Peter S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899416/ https://www.ncbi.nlm.nih.gov/pubmed/35248827 http://dx.doi.org/10.1016/j.redox.2022.102251 |
Ejemplares similares
-
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
por: Banerji, Christopher R S, et al.
Publicado: (2021) -
Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity
por: Banerji, Christopher R S, et al.
Publicado: (2020) -
An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy
por: Cowley, Matthew V, et al.
Publicado: (2023) -
Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2019) -
Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy
por: Pruller, Johanna, et al.
Publicado: (2020)